Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $44.7300 (1.06%) ($44.7300 - $44.7300) on Mon. Oct. 17, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.99% (three month average) | RSI | 85 | Latest Price | $44.7300(1.06%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.6% a day on average for past five trading days. | Weekly Trend | HALO advances 4.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(39%) IFRA(33%) IWM(32%) IWO(32%) IWN(31%) | Factors Impacting HALO price | HALO will decline at least -0.995% in a week (0% probabilities). VIXM(-10%) VXX(-6%) TBT(-3%) UUP(-1%) USO(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.995% (StdDev 1.99%) | Hourly BBV | 0.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $43.41(3.04%) | 10 Day Moving Average | $42.56(5.1%) | 20 Day Moving Average | $41.05(8.96%) | To recent high | -13.7% | To recent low | 16.2% | Market Cap | $6.113b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |